130 related articles for article (PubMed ID: 17444627)
1. Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-associated factor.
Pan C; Mezei M; Mujtaba S; Muller M; Zeng L; Li J; Wang Z; Zhou MM
J Med Chem; 2007 May; 50(10):2285-8. PubMed ID: 17444627
[TBL] [Abstract][Full Text] [Related]
2. Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.
Zeng L; Li J; Muller M; Yan S; Mujtaba S; Pan C; Wang Z; Zhou MM
J Am Chem Soc; 2005 Mar; 127(8):2376-7. PubMed ID: 15724976
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 tat transcriptional activity is regulated by acetylation.
Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
[TBL] [Abstract][Full Text] [Related]
4. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.
Deng L; de la Fuente C; Fu P; Wang L; Donnelly R; Wade JD; Lambert P; Li H; Lee CG; Kashanchi F
Virology; 2000 Nov; 277(2):278-95. PubMed ID: 11080476
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.
Deng L; Wang D; de la Fuente C; Wang L; Li H; Lee CG; Donnelly R; Wade JD; Lambert P; Kashanchi F
Virology; 2001 Oct; 289(2):312-26. PubMed ID: 11689053
[TBL] [Abstract][Full Text] [Related]
6. Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation.
Ott M; Dorr A; Hetzer-Egger C; Kaehlcke K; Schnolzer M; Henklein P; Cole P; Zhou MM; Verdin E
Novartis Found Symp; 2004; 259():182-93; discussion 193-6, 223-5. PubMed ID: 15171254
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.
Wong K; Sharma A; Awasthi S; Matlock EF; Rogers L; Van Lint C; Skiest DJ; Burns DK; Harrod R
J Biol Chem; 2005 Mar; 280(10):9390-9. PubMed ID: 15611041
[TBL] [Abstract][Full Text] [Related]
8. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
Zhao C; Chen Y; Park J; Kim JB; Tang H
Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
[TBL] [Abstract][Full Text] [Related]
9. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain.
Mujtaba S; He Y; Zeng L; Farooq A; Carlson JE; Ott M; Verdin E; Zhou MM
Mol Cell; 2002 Mar; 9(3):575-86. PubMed ID: 11931765
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.
Marzio G; Tyagi M; Gutierrez MI; Giacca M
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13519-24. PubMed ID: 9811832
[TBL] [Abstract][Full Text] [Related]
13. Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes.
Chipitsyna G; Sawaya BE; Khalili K; Amini S
J Cell Physiol; 2006 Jun; 207(3):605-13. PubMed ID: 16511829
[TBL] [Abstract][Full Text] [Related]
14. Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain.
Ariumi Y; Kaida A; Hatanaka M; Shimotohno K
Biochem Biophys Res Commun; 2001 Sep; 287(2):556-61. PubMed ID: 11554765
[TBL] [Abstract][Full Text] [Related]
15. Transactivator of transcription from HIV type 1 subtype E selectively inhibits TNF gene expression via interference with chromatin remodeling of the TNF locus.
Ranjbar S; Rajsbaum R; Goldfeld AE
J Immunol; 2006 Apr; 176(7):4182-90. PubMed ID: 16547255
[TBL] [Abstract][Full Text] [Related]
16. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat.
Benkirane M; Chun RF; Xiao H; Ogryzko VV; Howard BH; Nakatani Y; Jeang KT
J Biol Chem; 1998 Sep; 273(38):24898-905. PubMed ID: 9733796
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 regulates HIV transcription via Tat deacetylation.
Pagans S; Pedal A; North BJ; Kaehlcke K; Marshall BL; Dorr A; Hetzer-Egger C; Henklein P; Frye R; McBurney MW; Hruby H; Jung M; Verdin E; Ott M
PLoS Biol; 2005 Feb; 3(2):e41. PubMed ID: 15719057
[TBL] [Abstract][Full Text] [Related]
18. The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms.
Lassot I; Latreille D; Rousset E; Sourisseau M; Linares LK; Chable-Bessia C; Coux O; Benkirane M; Kiernan RE
Mol Cell; 2007 Feb; 25(3):369-83. PubMed ID: 17289585
[TBL] [Abstract][Full Text] [Related]
19. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation.
Nagy Z; Tora L
Oncogene; 2007 Aug; 26(37):5341-57. PubMed ID: 17694077
[TBL] [Abstract][Full Text] [Related]
20. p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28.
Amini S; Mameli G; Del Valle L; Skowronska A; Reiss K; Gelman BB; White MK; Khalili K; Sawaya BE
Mol Cell Biol; 2005 Sep; 25(18):8126-38. PubMed ID: 16135803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
